Related Experiment Video
Updated: Mar 3, 2026

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
Evaluation of artificial intelligence-based electrocardiogram analysis tools in patients with hypertrophic
Gamze Babur Guler1, Arda Guler1, Ozgur Surgit1
1Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, Cardiology, Istanbul, Turkey.
Insights
Artificial intelligence (AI) tools for electrocardiogram (ECG) analysis showed limited accuracy in identifying hypertrophic cardiomyopathy (HCM) patients. Further validation is needed before widespread clinical use of these AI ECG tools in specialized cardiac populations.
Area of Science:
- Cardiology
- Artificial Intelligence
- Medical Diagnostics
Background:
- Artificial intelligence (AI) tools for electrocardiogram (ECG) analysis show promise for cardiac condition detection.
- The performance of these AI tools in specific patient groups, like hypertrophic cardiomyopathy (HCM), is not fully understood.
Purpose of the Study:
- To evaluate the effectiveness of three AI-based ECG analysis tools in patients with confirmed HCM.
- Assess AI tools for calculating HCM probability, structural heart disease (SHD) probability, and providing ECG-based diagnoses.
Main Methods:
- Digitized 12-lead ECGs from 681 HCM patients were analyzed using three AI tools.
- Assessed AI-calculated probability distributions, clinical parameter associations, and agreement with manual diagnoses using Cohen's kappa.
Main Results:
- AI-calculated HCM probabilities had a median of 38.8%, with only 41.2% of patients scoring >50%.
- HCM probabilities correlated with abnormal ECGs and disease severity markers.
- SHD probabilities were higher, with a median of 51.4%, and 51.2% of patients scoring >50%.
Conclusions:
- AI ECG analysis tools exhibited modest performance in the HCM cohort.
- Challenges exist in applying general AI models to specific disease populations.
- Disease-specific validation is crucial for AI tools before clinical implementation in cardiology.
Aims:
Artificial intelligence (AI)-based electrocardiogram (ECG) analysis tools have shown promise in detecting various cardiac conditions. However, their performance in specific patient populations, such as those with hypertrophic cardiomyopathy (HCM), remains incompletely characterized. To evaluate the performance of three AI-based ECG analysis tools in patients with confirmed HCM: (1) a tool calculating HCM probability, (2) a tool calculating structural heart disease (SHD) probability, and (3) a tool providing ECG-based diagnoses across multiple categories.
Methods And Results:
We analysed digitized 12-lead ECGs from patients with confirmed HCM (n = 681) using three AI tools. We assessed the distribution of AI-calculated probabilities and their associations with clinical parameters and evaluated agreement between AI-based and manually assigned ECG diagnoses using Cohen's kappa. Despite all patients having confirmed HCM, the AI-calculated HCM probabilities showed a relatively uniform distribution [median 38.8% (IQR: 12.8-63.4%)], with only 41.2% and 12.5% of patients receiving a probability score >50% and >75%. HCM probabilities were significantly higher in patients with abnormal vs. normal ECGs (P < 0.001) and correlated with markers of disease severity. SHD probabilities were generally higher [median 51.4% (IQR: 28.7-74.5%)], with 51.2% and 25% of patients receiving scores >50% and >75%.
Conclusion:
AI-based ECG analysis tools demonstrated modest performance in our HCM cohort. These findings highlight the challenges of applying AI tools developed in general populations to specific disease cohorts and underscore the need for disease-specific validation before clinical implementation.
Related Concept Videos
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Dysrhythmias V: Evaluating Dysrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy V: Interprofessional Care

